Cost-effectiveness analysis of telaprevir triple therapy for treatment-naive patients with chronic hepatitis C based on the combined efficacy data of the ADVANCE and OPTIMIZE studies

dc.contributor.author	Turnes Vázquez, Juan
dc.date.accessioned	2017-06-07T07:03:33Z
dc.date.available	2017-06-07T07:03:33Z
dc.date.issued	2013
dc.identifier.issn	0270-9139
dc.identifier.uri	http://hdl.handle.net/20.500.11940/2124
dc.language.iso	eng
dc.title	Cost-effectiveness analysis of telaprevir triple therapy for treatment-naive patients with chronic hepatitis C based on the combined efficacy data of the ADVANCE and OPTIMIZE studies
dc.type	Publicación de congreso
dc.authorsophos	Buti, M.
dc.authorsophos	Gros, B.
dc.authorsophos	Oyaguez, I.
dc.authorsophos	Andrade, R. J.
dc.authorsophos	Serra, M. A.
dc.authorsophos	Turnes, J.
dc.authorsophos	Casado, M. A.
dc.identifier.isi	330252205265
dc.identifier.sophos	12623
dc.issue.number	Suplemento 1
dc.journal.title	Hepatology
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Pontevedra e O Salnés - Complexo Hospitalario Universitario de Pontevedra::Dixestivo
dc.page.initial	1133A
dc.page.final	1133A
dc.rights.accessRights	openAccess
dc.typesophos	Comunicaciones a congresos
dc.volume.number	58

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.